Search

Displaying results 6381 - 6390 of 10000 in total
  1. Drug

    Camphor leaf oil

    go.drugbank.com/drugs/DB14378
    Investigational

    Camphor leaf oil is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

  2. Drug

    Curcumin sulfate

    go.drugbank.com/drugs/DB14635
    Experimental

  3. Drug

    Nitarsone

    go.drugbank.com/drugs/DB11437
    ExperimentalVet approved

    Nitarsone is an organoarsenic compound. It is used as an additive in poultry feed to improve weight gain and feed efficiency, while preventing blackhead disease. … It is marketed as Histostat by Zoetis, a publicly traded subsidiary of Pfizer.

  4. Drug

    Pegnivacogin

    go.drugbank.com/drugs/DB06293
    Investigational

  5. Drug

    Mirostipen

    go.drugbank.com/drugs/DB06453
    Experimental

  6. Drug

    INO-1001

    go.drugbank.com/drugs/DB05549
    Investigational

    Synonyms: (9-(N-(3-Morpholinopropyl)-sulfonyl)-5,6-dihydro-5-oxo-11-H-indeno (1,2-C) isoquinoline methanesulfonic acid
  7. Drug

    Apilimod

    go.drugbank.com/drugs/DB05611
    Investigational

  8. Drug

    Sarizotan

    go.drugbank.com/drugs/DB06454
    Investigational

  9. Drug

    Seliciclib

    go.drugbank.com/drugs/DB06195
    Investigational

    R-roscovitine (Seliciclib or CYC202) is a cyclin-dependent kinase (CDK) inhibitor that preferentially inhibits multiple enzyme targets including CDK2, CDK7 and CDK9, which alter the growth phase of treated … Developed by Cyclacel, seliciclib is being researched for the treatment of non-small cell lung cancer (NSCLC), leukemia, HIV infection, herpes simplex infection, and the mechanisms of chronic inflammation

  10. Drug

    Egaptivon pegol

    go.drugbank.com/drugs/DB05202
    Investigational

    Egaptivon pegol, formerly known as ARC1779, is a therapeutic aptamer antagonist of the A1 domain of von Willebrand Factor (vWF), the ligand for receptor glycoprotein 1b on platelets. … Egaptivon pegol is being investigated for the treatment of thrombotic thrombocytopenic purpura and acute coronary syndromes.